Market Cap 2.06M
Revenue (ttm) 410,000.00
Net Income (ttm) -9.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,397.56%
Debt to Equity Ratio 0.00
Volume 33,100
Avg Vol 1,772,198
Day's Range N/A - N/A
Shares Out 655,000.00
Stochastic %K 15%
Beta 1.11
Analysts Strong Sell
Price Target $6.50

Company Profile

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic c...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 924 1114
Fax: 972 3 924 9378
Address:
26 Ben Gurion Street, Ramat Gan, Israel
Merlintrader
Merlintrader Jul. 30 at 5:21 PM
$CANF Can-Fite BioPharma Stock Hub: Namodenoson, Pancreatic Cancer, HCC, MASH and the Nano-Cap Dilution Puzzle https://www.merlintrader.com/can-fite-biopharma-stock-hub/
0 · Reply
translucide
translucide Jul. 30 at 12:38 AM
$CANF Should go down to 1.50 in the next month, they will issue warrants again for approx 6m$ very soon ! They seem to always need more money at this time of year.
0 · Reply
Peaceouty
Peaceouty Jul. 29 at 6:06 PM
$CANF the entire company is on vacation for the past 20 years or what?
0 · Reply
Davefuhr
Davefuhr Jul. 29 at 4:13 AM
$CANF Lending rate niw 111%. Need some good news to keep shorts from driving this down!
0 · Reply
Davefuhr
Davefuhr Jul. 24 at 5:23 PM
$CANF Lending rate now 107 %. Why do traders want to short a company developing useful medicines this badly? When will they cover?
0 · Reply
Pagovski
Pagovski Jul. 24 at 7:03 AM
$CANF i'd bet money that @Donniechen12345 is sooper short on this one lol
1 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Jul. 24 at 5:06 AM
Stocks Under $5 to Watch Tomorrow (July 24, 2026): $RR $BBAI $SURG $CANF $IDAI https://truthsandnews.com/markets/top-10-penny-stocks-under-5-to-watch-tomorrow-july-24-2026
0 · Reply
AZOZ
AZOZ Jul. 23 at 1:59 PM
$CANF Catalyst ahed!
0 · Reply
focafoca99
focafoca99 Jul. 20 at 11:18 AM
$CANF shared positive Phase 2a pancreatic cancer data, now accepted for presentation at ESMO 2026.
0 · Reply
Donniechen12345
Donniechen12345 Jul. 19 at 2:56 PM
$CANF if you keep using those fake short rate interest numbers as an excuse to NOt sell and move on is dumb and stupid period!! , donnie guaranteed you will GO broke and be forever dumb and stupid !!!!!! and its NOt even shortable , cant short for donnie , those short interest number are FAKE numbers just to make LONGs to think more and more and dont sell lmao……….. You Longs holding and finding whaver excuse there to hold this trash stocks is ridiculous smh . victim of a ponzi scheme and dont even realized it OUCH!!!!
2 · Reply
Latest News on CANF
Can-Fite BioPharma (CANF) Secures Patent for Cancer Treatment

2026-07-14T12:30:17.000Z - 21 days ago

Can-Fite BioPharma (CANF) Secures Patent for Cancer Treatment


Can-Fite BioPharma enrolls 247 patients in Piclidenoson trial

2026-07-06T11:15:42.000Z - 4 weeks ago

Can-Fite BioPharma enrolls 247 patients in Piclidenoson trial


Can-Fite BioPharma Registration statement: Registration filing

Mar 31, 2026, 8:00 AM EDT - 4 months ago

Can-Fite BioPharma Registration statement: Registration filing


Can-Fite BioPharma completes enrollment in Piclidenoson study

2026-03-30T11:37:18.000Z - 4 months ago

Can-Fite BioPharma completes enrollment in Piclidenoson study


Can-Fite BioPharma Annual report: Q4 2025

Mar 26, 2026, 9:30 AM EDT - 4 months ago

Can-Fite BioPharma Annual report: Q4 2025


Can-Fite BioPharma Quarterly report: Q4 2025

Mar 26, 2026, 9:30 AM EDT - 4 months ago

Can-Fite BioPharma Quarterly report: Q4 2025


Can-Fite BioPharma provides clinical, financial update

2025-12-16T14:25:37.000Z - 8 months ago

Can-Fite BioPharma provides clinical, financial update


Can-Fite Provides Update on Clinical and Financial Status

Dec 16, 2025, 9:19 AM EST - 8 months ago

Can-Fite Provides Update on Clinical and Financial Status


Can-Fite BioPharma Quarterly report: Q2 2025

Aug 27, 2025, 6:00 PM EDT - 1 year ago

Can-Fite BioPharma Quarterly report: Q2 2025


Can-Fite Announces Up To $15.0 Million Public Offering

Jul 28, 2025, 12:24 PM EDT - 1 year ago

Can-Fite Announces Up To $15.0 Million Public Offering


Can-Fite BioPharma Annual report: Q4 2024

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Can-Fite BioPharma Annual report: Q4 2024


Can-Fite BioPharma Quarterly report: Q4 2024

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Can-Fite BioPharma Quarterly report: Q4 2024


Can-Fite BioPharma Transcript: C-level Sitdown

Nov 23, 2024, 7:01 PM EST - 1 year ago

Can-Fite BioPharma Transcript: C-level Sitdown


Can-Fite BioPharma Transcript: Investor Update

Oct 29, 2024, 4:15 PM EDT - 1 year ago

Can-Fite BioPharma Transcript: Investor Update


Can-Fite BioPharma Registration statement: Registration Filing

Aug 30, 2024, 8:00 AM EDT - 2 years ago

Can-Fite BioPharma Registration statement: Registration Filing


Can-Fite BioPharma Earnings release: Q2 2024

Aug 29, 2024, 7:00 AM EDT - 2 years ago

Can-Fite BioPharma Earnings release: Q2 2024


Can-Fite BioPharma Transcript: C-level Sitdown

Aug 10, 2024, 7:00 PM EDT - 2 years ago

Can-Fite BioPharma Transcript: C-level Sitdown


Can-Fite BioPharma Transcript: Investor Update

Aug 8, 2024, 4:15 PM EDT - 2 years ago

Can-Fite BioPharma Transcript: Investor Update


Can-Fite Provides Namodenoson Patent Update

Jul 29, 2024, 7:00 AM EDT - 2 years ago

Can-Fite Provides Namodenoson Patent Update


Can-Fite BioPharma Transcript: Investor Update

Jun 6, 2024, 4:15 PM EDT - 2 years ago

Can-Fite BioPharma Transcript: Investor Update


Merlintrader
Merlintrader Jul. 30 at 5:21 PM
$CANF Can-Fite BioPharma Stock Hub: Namodenoson, Pancreatic Cancer, HCC, MASH and the Nano-Cap Dilution Puzzle https://www.merlintrader.com/can-fite-biopharma-stock-hub/
0 · Reply
translucide
translucide Jul. 30 at 12:38 AM
$CANF Should go down to 1.50 in the next month, they will issue warrants again for approx 6m$ very soon ! They seem to always need more money at this time of year.
0 · Reply
Peaceouty
Peaceouty Jul. 29 at 6:06 PM
$CANF the entire company is on vacation for the past 20 years or what?
0 · Reply
Davefuhr
Davefuhr Jul. 29 at 4:13 AM
$CANF Lending rate niw 111%. Need some good news to keep shorts from driving this down!
0 · Reply
Davefuhr
Davefuhr Jul. 24 at 5:23 PM
$CANF Lending rate now 107 %. Why do traders want to short a company developing useful medicines this badly? When will they cover?
0 · Reply
Pagovski
Pagovski Jul. 24 at 7:03 AM
$CANF i'd bet money that @Donniechen12345 is sooper short on this one lol
1 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Jul. 24 at 5:06 AM
Stocks Under $5 to Watch Tomorrow (July 24, 2026): $RR $BBAI $SURG $CANF $IDAI https://truthsandnews.com/markets/top-10-penny-stocks-under-5-to-watch-tomorrow-july-24-2026
0 · Reply
AZOZ
AZOZ Jul. 23 at 1:59 PM
$CANF Catalyst ahed!
0 · Reply
focafoca99
focafoca99 Jul. 20 at 11:18 AM
$CANF shared positive Phase 2a pancreatic cancer data, now accepted for presentation at ESMO 2026.
0 · Reply
Donniechen12345
Donniechen12345 Jul. 19 at 2:56 PM
$CANF if you keep using those fake short rate interest numbers as an excuse to NOt sell and move on is dumb and stupid period!! , donnie guaranteed you will GO broke and be forever dumb and stupid !!!!!! and its NOt even shortable , cant short for donnie , those short interest number are FAKE numbers just to make LONGs to think more and more and dont sell lmao……….. You Longs holding and finding whaver excuse there to hold this trash stocks is ridiculous smh . victim of a ponzi scheme and dont even realized it OUCH!!!!
2 · Reply
Donniechen12345
Donniechen12345 Jul. 19 at 2:50 PM
$CANF you brainwashed longs WILL some day wake up and realized youre a victim of a ponzi schme smh , cant hell you until you let go this Big egos of yours smh
0 · Reply
Donniechen12345
Donniechen12345 Jul. 19 at 2:47 PM
$CANF its not even shortable and you brainwashed idiots keep using short interest rate as an excuse to hold this trash forever smh … and being a victim of a ponzi scheme and dont even realized it wow ouch……. after 18times of scam dilution offering and reversed split rinse and repeat !!! you idiots still brainwashed ehhh…. lmao
0 · Reply
Donniechen12345
Donniechen12345 Jul. 19 at 2:39 PM
$CANF Somadoja youre an idiot and brainwashed and a victim of a ponzo scheme and dont even realized it , i know it hurts , love up to it boy smh 🤦‍♀️
0 · Reply
Donniechen12345
Donniechen12345 Jul. 19 at 2:36 PM
$CANF Davefuhr youre an idiot smh and a brainwashed one too smh , you're helpless hehe .hehe .
0 · Reply
Donniechen12345
Donniechen12345 Jul. 19 at 2:33 PM
$CANF still holding and buy this trash dilution offering and reverse scam ponzo stock machine ehhhh???? lmao …… Will do another pump soon and scamm invervestors for free $ millions at idiots investors cost and yet another reverse split after that for the 18th times in 3 years lmao hahaha . please stay away from this scam ponzi scheme stocks !!!!!!!!!!!! Stay away hahaha . will drop below $1 by august and then another reverse split or pump and then dump hard lmao $$$…. this company survives with vacations and bonus for execs from scammofferings the last 18th time lmao ,,,,, all those scam $70,000,000 that they stole from investors , Not one penny goes into the stocck value ,,,, Zero penny!!!!!!!’ lol no buy back shares or whatso ever used from those $70,000,000 all went to them to spend on vacation and bomuses ans exotic cars lmao !!!!!! stay the fuc away from this SCAM company , they know how tonuse the loopholes !!!!!!’n hahahh
0 · Reply
Davefuhr
Davefuhr Jul. 18 at 3:09 PM
$CANF This morning the lending rate is 101.5. Still going up.
1 · Reply
Alex1710
Alex1710 Jul. 16 at 10:35 PM
$CANF If someone can comment on this you're welcome.
0 · Reply
Alex1710
Alex1710 Jul. 16 at 10:34 PM
$CANF I just sent this e-mail to the company: Good day, how do you compare to Takeda’s Zasocitinib that achieve complete skin clearance (PASI 100) at week 16 . https://www.takeda.com/newsroom/newsreleases/2026/zasocitinib-outperforms-deucravacitinib-study/
0 · Reply
Davefuhr
Davefuhr Jul. 16 at 4:36 PM
$CANF Lending rate went up to 94.5 %. Hope it jeros going up until they need to cover.
1 · Reply
Somadoja
Somadoja Jul. 16 at 2:17 PM
$CANF wow muting donniechen sure makes this whole page more readable, now let's wait phase 3 data :)
1 · Reply